NIH-funded research R21 grant

Lymphoid follicles on a chip to study aging-related immune dysfunction

Official title: Spatially Validated Human Lymphoid Follicles-on-Chip for Modeling Inflammaging and Age-Related Immune Dysfunction

Funded at Beth Israel Deaconess Medical Center · NIH-11442957 · Data updated 2026-11-12

A patient-centered look at how aging changes our immune system, using a human lymphoid tissue on a chip to model aging and immune responses.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2028
Funding year2026
Award (this year)$518,555
NIH project number1R21AG102442-01
Project IDNIH-11442957 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults experiencing age-related immune changes or vascular/metabolic conditions linked to inflammaging, who could benefit from improved vaccines or immune therapies in the future.

Less likely to help

The study is laboratory-based and may not directly involve participants; results may not apply to every individual.

What this research studies

This project uses a human lymphoid follicle organ-on-a-chip to recreate aging-related immune changes in a dish, helping scientists understand why elderly people have weaker or altered antibody responses. The team combines the LF-Chip with advanced imaging and gene profiling to map where and how immune cells organize and become activated over time. By simulating recurrent infections, researchers aim to uncover why chronic inflammation occurs with age and how it affects antibody production. The work starts from validated human tissue models and progresses toward deeper insights that could inform better vaccines and therapies for older adults.

Why it matters

Potential benefit: If successful, this research could lead to better vaccine strategies and therapies that bolster immune function in aging individuals.

How similar studies have gone: Similar organ-on-chip approaches have shown faithful replication of human immune features and are promising for translating findings to patients.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Jiang, Sizun — Beth Israel Deaconess Medical Center
  • Study coordinator: Jiang, Sizun

Related research

Other NIH-funded projects on the same topics.

  • SATURN MRI ancillary study: statins after intracerebral hemorrhage and brain MRI markers

    This study looks at what happens to brain MRI markers and health outcomes when people with a specific type of brain bleed continue or stop taking statins.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625633

  • Statin use after brain bleed MRI study in ICH patients (SATURN MRI) Ancillary Study

    This project tests whether continuing or stopping statin therapy after an intracerebral hemorrhage affects brain changes seen on MRI and related health outcomes in people with lobar ICH.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625632

  • Statin use after brain bleed: SATURN MRI ancillary study

    This project tests whether continuing statin medicines after a brain bleed (lobar intracerebral hemorrhage) affects new brain blood vessel findings and long-term health.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11625628

  • XenCAT: Single Cell Atlas for Xenopus

    Aims to map gene activity at the single-cell level in Xenopus to help understand how cells develop and how this relates to human disease.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11594482

  • Statin use after lobar intracerebral hemorrhage

    This trial compares continuing versus stopping statins in people who had a lobar intracerebral hemorrhage to see how that affects repeat brain bleeds, strokes, heart attacks, and recovery over two years.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518526

  • Statin use after lobar brain hemorrhage

    This trial compares stopping versus continuing statin medicine in people who had a lobar brain bleed to learn effects on repeat bleeding and future heart or stroke events.

    NIH research Beth Israel Deaconess Medical Center · Boston, United States · NIH-11518525

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.